Assessing the role of ADAM10 in Trastuzumab treatment and resistance
<p>Overexpression of the HER2 receptor occurs in about 15-20% of all breast cancers and is correlated with poor prognosis. Trastuzumab (Herceptin®), a monoclonal antibody targeting HER2, was shown to prolong survival of these patients. However, primary or acquired resistance remains a drawback...
Prif Awdur: | Feldinger, K |
---|---|
Awduron Eraill: | Kong, A |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
2012
|
Pynciau: |
Eitemau Tebyg
-
Functional organisation of the Hrd1 ubiquitin ligase complex and its role in ERAD
gan: Schulz, J
Cyhoeddwyd: (2013) -
The role and regulation of Asterless in the centrosome cycle
gan: Novak, ZA
Cyhoeddwyd: (2014) -
Characterisation of AEBP2: a polycomb repressive complex 2 component
gan: Grijzenhout, A
Cyhoeddwyd: (2013) -
Cell stress response and hypoxia in breast cancer
gan: Milani, M, et al.
Cyhoeddwyd: (2011) -
Nitric oxide: a chemical effector of pathogenesis in magnaporthe oryzae
gan: Johnson, J
Cyhoeddwyd: (2011)